APA (7th ed.) Citation

Eraslan, E., Yildiz, F., Tufan, G., Aslan, F., Demirci, U., & Oksuzoglu, O. B. (2019). First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience. Galenos Publishing House.

Chicago Style (17th ed.) Citation

Eraslan, Emrah, Fatih Yildiz, Gulnihal Tufan, Ferit Aslan, Umut Demirci, and Omur Berna Oksuzoglu. First Line Modified Folfirinox Versus Gemcitabine for Advanced Pancreatic Cancer: A Single Institution Retrospective Experience. Galenos Publishing House, 2019.

MLA (9th ed.) Citation

Eraslan, Emrah, et al. First Line Modified Folfirinox Versus Gemcitabine for Advanced Pancreatic Cancer: A Single Institution Retrospective Experience. Galenos Publishing House, 2019.